DEXTROTHYROXINE SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for dextrothyroxine sodium and what is the scope of patent protection?
Dextrothyroxine sodium
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for DEXTROTHYROXINE SODIUM
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,508 |
| DailyMed Link: | DEXTROTHYROXINE SODIUM at DailyMed |
Recent Clinical Trials for DEXTROTHYROXINE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 1/Phase 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | N/A |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXTROTHYROXINE SODIUM
US Patents and Regulatory Information for DEXTROTHYROXINE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | CHOLOXIN | dextrothyroxine sodium | TABLET;ORAL | 012302-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
